Randomized trial assesses ethnobotanical importance and conservation needs of Himalayan Mayapple in Pakistan, suggesting urgent intervention.
Podophyllum hexandrum Royle (1834) (Himalayan Mayapple), a key Himalayan medicinal plant and source of podophyllotoxin for anticancer drugs, is declining due to overharvesting, habitat loss, and climate change. This study, conducted from May to September 2024 across nine populations in Swat, Pakistan, assessed its ethnobotanical importance and conservation status. A total of 331 participants (270 individual surveys + 61 group discussions) were included. Using ethnobotanical surveys, IUCN-CMP threat frameworks, and spatial analysis, results showed high cultural value (Use Value = 0.63–0.92) and strong consensus for rheumatism (ICF = 0.91) and fever (ICF = 0.89). Fidelity levels were 94% for rheumatism and 88% for fever. Only 35% of respondents demonstrated conservation awareness. Overharvesting was the main threat, followed by habitat degradation and climate change. The species showed restricted distribution (EOO = 4250 km2; AOO = 295 km2), high fragmentation (0.68), and a 35% population decline over 10 years. It is assessed as Endangered (EN B1ab (iii, v)). This study provides the first integrated ethnobotanical–GIS assessment of P. hexandrum in the Hindu Kush–Himalaya region of Pakistan, offering measurable conservation baselines and community perception data previously unavailable. Findings align with global medicinal plant decline trends and support integration with CBD, SDGs (3 and 15), and potential CITES listing. Urgent conservation actions are required, including community-based management, habitat restoration, sustainable harvesting, ex situ conservation, and policy enforcement.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: